{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:27:13Z","timestamp":1792114033392,"version":"4.4.0"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejphar.2026.178721","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:15:21Z","timestamp":1772558121000},"page":"178721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Bridging protein quality control and epigenetic dysregulation: The HDAC6 paradox in neurological disorders and therapeutic targeting"],"prefix":"10.1016","volume":"1019","author":[{"given":"Yuhan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7599-6533","authenticated-orcid":false,"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178721_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1242\/dmm.002527","article-title":"An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of charcot-marie-tooth type 2D peripheral neuropathy","volume":"2","author":"Achilli","year":"2009","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ejphar.2026.178721_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/hmg\/ddi452","article-title":"A mutation in the small heat-shock protein HSPB1 leading to distal hereditary motor neuronopathy disrupts neurofilament assembly and the axonal transport of specific cellular cargoes","volume":"15","author":"Ackerley","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2026.178721_bib3","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1038\/ncomms3532","article-title":"Septins promote dendrite and axon development by negatively regulating microtubule stability via HDAC6-mediated deacetylation","volume":"4","author":"Ageta-Ishihara","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.178721_bib4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1471-4159.2002.00836.x","article-title":"The effects of focal ischemia and reperfusion on the glutathione content of mitochondria from rat brain subregions","volume":"81","author":"Anderson","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2026.178721_bib5","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1242\/jcs.038950","article-title":"Structural determinants of the cellular localization and shuttling of TDP-43","volume":"121","author":"Ayala","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejphar.2026.178721_bib6","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1038\/s41598-022-10518-z","article-title":"HDAC6 regulates NF-kappaB signalling to control chondrocyte IL-1-induced MMP and inflammatory gene expression","volume":"12","author":"Barter","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.178721_bib7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/brain\/awx375","article-title":"HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease","volume":"141","author":"Benoy","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2026.178721_bib8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s13311-016-0501-z","article-title":"Development of improved HDAC6 inhibitors as pharmacological therapy for axonal Charcot-Marie-Tooth disease","volume":"14","author":"Benoy","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejphar.2026.178721_bib9","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1021\/jm301098e","article-title":"Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth","volume":"55","author":"Bergman","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178721_bib10","doi-asserted-by":"crossref","first-page":"48246","DOI":"10.1074\/jbc.M408583200","article-title":"Role of the tetradecapeptide repeat domain of human histone deacetylase 6 in cytoplasmic retention","volume":"279","author":"Bertos","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.178721_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1139\/o01-032","article-title":"Class II histone deacetylases: structure, function, and regulation","volume":"79","author":"Bertos","year":"2001","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.ejphar.2026.178721_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020696","article-title":"Hdac6 knock-out increases tubulin acetylation but does not modify disease progression in the R6\/2 mouse model of Huntington's disease","volume":"6","author":"Bobrowska","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.178721_bib13","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1101\/gad.436407","article-title":"HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates","volume":"21","author":"Boyault","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejphar.2026.178721_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1231659","article-title":"HDAC-6 inhibition ameliorates the early neuropathology in a mouse model of Krabbe disease","volume":"16","author":"Braz","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178721_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1021\/acs.jmedchem.9b00924","article-title":"Old but gold: tracking the new guise of histone deacetylase 6 (HDAC6) enzyme as a biomarker and therapeutic target in rare diseases","volume":"63","author":"Brindisi","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178721_bib16","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A","volume":"132","author":"Butler","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejphar.2026.178721_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061455","article-title":"Pseudophosphatase MK-STYX alters histone deacetylase 6 cytoplasmic localization, decreases its phosphorylation, and increases detyrosination of tubulin","volume":"20","author":"Cao","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178721_bib18","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1242\/jcs.048975","article-title":"The NIMA-family kinase Nek3 regulates microtubule acetylation in neurons","volume":"122","author":"Chang","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejphar.2026.178721_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001288","article-title":"Pathogenic VCP\/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model","volume":"7","author":"Chang","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ejphar.2026.178721_bib20","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.bmcl.2005.01.006","article-title":"Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitors","volume":"15","author":"Chen","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2026.178721_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109803","article-title":"HDAC6 inhibitor ACY-1215 improves neuropathic pain and its comorbidities in rats of peripheral nerve injury by regulating neuroinflammation","volume":"353","author":"Chen","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2026.178721_bib22","doi-asserted-by":"crossref","DOI":"10.1042\/AN20100019","article-title":"Mitochondria and neuroplasticity","volume":"2","author":"Cheng","year":"2010","journal-title":"ASN Neuro"},{"key":"10.1016\/j.ejphar.2026.178721_bib23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12974-025-03400-y","article-title":"Inhibition of histone deacetylase 6 alleviates neuropathic pain via direct regulating post-translation of spinal STAT3 and decreasing downstream C-C motif chemokine ligand 7 synthesis","volume":"22","author":"Chi","year":"2025","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2026.178721_bib24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.conb.2014.03.008","article-title":"HDAC signaling in neuronal development and axon regeneration","volume":"27","author":"Cho","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.ejphar.2026.178721_bib25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/ncomms1255","article-title":"The acetylation of tau inhibits its function and promotes pathological tau aggregation","volume":"2","author":"Cohen","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.178721_bib26","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1093\/hmg\/ddq050","article-title":"Transgenic mice expressing mutant forms VCP\/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone","volume":"19","author":"Custer","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2026.178721_bib27","series-title":"HDAC6 at the Intersection of Neuroprotection and Neurodegeneration. Traffic 13","first-page":"771","author":"d'Ydewalle","year":"2012"},{"key":"10.1016\/j.ejphar.2026.178721_bib28","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nm.2396","article-title":"HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease","volume":"17","author":"d'Ydewalle","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2026.178721_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130318","article-title":"Histone deacetylase 6 inhibitors in Alzheimer's disease therapy: structure design and challenges","volume":"127","author":"Dang","year":"2025","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2026.178721_bib30","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family","volume":"370","author":"de Ruijter","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2026.178721_bib31","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/cmdc.201900174","article-title":"Histone deacetylase inhibitors as multitarget ligands: new players in Alzheimer's disease drug discovery?","volume":"14","author":"De Simone","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejphar.2026.178721_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.neuro.31.061307.090711","article-title":"Role of axonal transport in neurodegenerative diseases","volume":"31","author":"De Vos","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178721_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/1868-7083-4-5","article-title":"Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors","volume":"4","author":"Delcuve","year":"2012","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.ejphar.2026.178721_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature10353","article-title":"Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS\/dementia","volume":"477","author":"Deng","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2026.178721_bib35","article-title":"Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6","volume":"2","author":"Deribe","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejphar.2026.178721_bib36","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/j.1471-4159.2008.05564.x","article-title":"Histone deacetylase 6 interacts with the microtubule-associated protein tau","volume":"106","author":"Ding","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2026.178721_bib37","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1523\/JNEUROSCI.0037-07.2007","article-title":"Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation","volume":"27","author":"Dompierre","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178721_bib38","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.bbapap.2016.06.007","article-title":"The world of protein acetylation","volume":"1864","author":"Drazic","year":"2016","journal-title":"Bba Proteins Proteom."},{"key":"10.1016\/j.ejphar.2026.178721_bib39","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1091\/mbc.e10-03-0200","article-title":"Drosophila histone deacetylase 6 protects dopaminergic neurons against alpha-synuclein toxicity by promoting inclusion formation","volume":"21","author":"Du","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejphar.2026.178721_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004049","article-title":"The roles of post-translational modifications in the context of protein interaction networks","volume":"11","author":"Duan","year":"2015","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejphar.2026.178721_bib41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature02625","article-title":"Epigenetics in human disease and prospects for epigenetic therapy","volume":"429","author":"Egger","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2026.178721_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.684714","article-title":"HDAC6: a key link between mitochondria and development of peripheral neuropathy","volume":"14","author":"English","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178721_bib43","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41419-018-0688-5","article-title":"The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model","volume":"9","author":"Fan","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2026.178721_bib44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.nbd.2005.10.010","article-title":"Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression","volume":"22","author":"Fortun","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2026.178721_bib45","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.nbd.2006.09.018","article-title":"The formation of peripheral myelin protein 22 aggregates is hindered by the enhancement of autophagy and expression of cytoplasmic chaperones","volume":"25","author":"Fortun","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2026.178721_bib46","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58591","article-title":"Transcriptional profiling of mouse peripheral nerves to the single-cell level to build a sciatic nerve ATlas (SNAT)","volume":"10","author":"Gerber","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.ejphar.2026.178721_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23062996","article-title":"Emerging role of HDACs in regeneration and ageing in the peripheral nervous system: repair schwann cells as pivotal targets","volume":"23","author":"Gomez-Sanchez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178721_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23062996","article-title":"Emerging role of HDACs in regeneration and ageing in the peripheral nervous system: repair schwann cells as pivotal targets","volume":"23","author":"Gomez-Sanchez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178721_bib49","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/j.bbadis.2015.08.012","article-title":"HDAC6 inhibition induces mitochondrial fusion, autophagic flux and reduces diffuse mutant huntingtin in striatal neurons","volume":"1852","author":"Guedes-Dias","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2026.178721_bib50","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41467-017-00911-y","article-title":"HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients","volume":"8","author":"Guo","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.178721_bib51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ejphar.2026.178721_bib52","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nchembio.2134","article-title":"Histone deacetylase 6 structure and molecular basis of catalysis and inhibition","volume":"12","author":"Hai","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejphar.2026.178721_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115613","article-title":"Perspectives and new aspects of histone deacetylase inhibitors in the therapy of CNS diseases","volume":"258","author":"Han","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178721_bib54","doi-asserted-by":"crossref","first-page":"8567","DOI":"10.1073\/pnas.0503221102","article-title":"Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma","volume":"102","author":"Hideshima","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2026.178721_bib55","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2007.01.043","article-title":"Activation of the unfolded protein response in Parkinson's disease","volume":"354","author":"Hoozemans","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2026.178721_bib56","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.18632\/oncotarget.13738","article-title":"Selective HDAC inhibition by ACY-241 enhances the activity of paclitaxel in solid tumor models","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2026.178721_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117218","article-title":"Small molecules targeting HDAC6 for cancer treatment: current progress and novel strategies","volume":"178","author":"Huang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.178721_bib58","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2026.178721_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071605","article-title":"HDAC6 modulates signaling pathways relevant to synaptic biology and neuronal differentiation in human stem-cell-derived neurons","volume":"20","author":"Iaconelli","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178721_bib60","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer disease and related tauopathies","volume":"7","author":"Iqbal","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejphar.2026.178721_bib61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jphs.2020.06.007","article-title":"TLR4-TAK1-p38 MAPK pathway and HDAC6 regulate the expression of sigma-1 receptors in rat primary cultured microglia","volume":"144","author":"Iwamoto","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2026.178721_bib62","doi-asserted-by":"crossref","first-page":"40282","DOI":"10.1074\/jbc.M508786200","article-title":"HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin","volume":"280","author":"Iwata","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.178721_bib63","article-title":"A next-generation HDAC6 inhibitor for amyotrophic lateral sclerosis and frontotemporal dementia","author":"James","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2026.178721_bib64","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neulet.2017.08.029","article-title":"Inhibition of HDAC6 increases acetylation of peroxiredoxin1\/2 and ameliorates 6-OHDA induced dopaminergic injury","volume":"658","author":"Jian","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2026.178721_bib65","article-title":"Human HDAC6 senses valine abundancy to regulate DNA damage","author":"Jin","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2026.178721_bib66","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/npp.2013.207","article-title":"Antidepressant-like properties of novel HDAC6-selective inhibitors with improved brain bioavailability","volume":"39","author":"Jochems","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.178721_bib67","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2010.11.036","article-title":"Exome sequencing reveals VCP mutations as a cause of familial ALS","volume":"68","author":"Johnson","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2026.178721_bib68","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/cbdv.200590118","article-title":"Rational design and development of radiation-sensitizing histone deacetylase inhibitors","volume":"2","author":"Jung","year":"2005","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejphar.2026.178721_bib69","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1083\/jcb.201702187","article-title":"Deacetylation of Miro1 by HDAC6 blocks mitochondrial transport and mediates axon growth inhibition","volume":"218","author":"Kalinski","year":"2019","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.178721_bib70","doi-asserted-by":"crossref","first-page":"8474","DOI":"10.1039\/D2FO00423B","article-title":"Wheatgrass extract imparts neuroprotective actions against scopolamine-induced amnesia in mice","volume":"13","author":"Katiyar","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.ejphar.2026.178721_bib71","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0092-8674(03)00939-5","article-title":"The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress","volume":"115","author":"Kawaguchi","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2026.178721_bib72","article-title":"HDAC6 inhibitor blocks amyloid beta-induced impairment of mitochondrial transport in hippocampal neurons","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.178721_bib73","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1021\/acschemneuro.8b00600","article-title":"Brain penetrable histone deacetylase 6 inhibitor SW-100 ameliorates memory and learning impairments in a mouse model of fragile X syndrome","volume":"10","author":"Kozikowski","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178721_bib74","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/j.pain.0000000000000893","article-title":"HDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy","volume":"158","author":"Krukowski","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.178721_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115367","article-title":"HDAC6 inhibition enhances peroxiredoxin 1 acetylation to mitigate oxidative stress and seizure activity in focal cortical dysplasia","volume":"392","author":"Kumar","year":"2025","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2026.178721_bib76","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.yexcr.2018.05.001","article-title":"iPSC-derived neurons profiling reveals GABAergic circuit disruption and acetylated alpha-tubulin defect which improves after iHDAC6 treatment in Rett syndrome","volume":"368","author":"Landucci","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejphar.2026.178721_bib77","doi-asserted-by":"crossref","first-page":"7087","DOI":"10.1021\/acs.jmedchem.8b00151","article-title":"5-Aroylindoles Act as selective histone deacetylase 6 inhibitors ameliorating Alzheimer's disease phenotypes","volume":"61","author":"Lee","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178721_bib78","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/acs.jmedchem.7b01404","article-title":"(N-Hydroxycarbonylbenylamino)quinolines as selective histone deacetylase 6 inhibitors suppress growth of multiple myeloma in vitro and in vivo","volume":"61","author":"Lee","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178721_bib79","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1113\/jphysiol.2011.224907","article-title":"Histone deacetylase 6 gates the synaptic action of acute stress in prefrontal cortex","volume":"590","author":"Lee","year":"2012","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2026.178721_bib80","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/ibd\/izz317","article-title":"Novel histone deacetylase 6 inhibitor CKD-506 inhibits NF-kappaB signaling in intestinal epithelial cells and macrophages and ameliorates acute and chronic murine colitis","volume":"26","author":"Lee","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejphar.2026.178721_bib81","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/emboj.2009.405","article-title":"HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy","volume":"29","author":"Lee","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2026.178721_bib82","article-title":"Minor spliceosomal 65K\/RNPC3 interacts with ANKRD11 and mediates HDAC3-Regulated histone deacetylation and transcription","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.ejphar.2026.178721_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113874","article-title":"Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: a review (2010-2020)","volume":"226","author":"Li","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178721_bib84","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1083\/jcb.200912001","article-title":"The small GTPases ARL-13 and ARL-3 coordinate intraflagellar transport and ciliogenesis","volume":"189","author":"Li","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.178721_bib85","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1021\/acsmedchemlett.5c00344","article-title":"Novel heterocyclic 5H-Dibenzo[b,f]azepine derivatives as selective HDAC6 inhibitors for treatment of charcot marie tooth disease","volume":"16","author":"Liang","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2026.178721_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167137","article-title":"Hippocampal HDAC6 promotes POCD by regulating NLRP3-induced microglia pyroptosis via HSP90\/HSP70 in aged mice","volume":"1870","author":"Lin","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.ejphar.2026.178721_bib87","doi-asserted-by":"crossref","first-page":"10080","DOI":"10.1021\/acs.jmedchem.3c00977","article-title":"Discovery of the first irreversible HDAC6 isoform selective inhibitor with potent anti-multiple myeloma activity","volume":"66","author":"Liu","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178721_bib88","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/WNR.0000000000001481","article-title":"Histone deacetylase-6 modulates amyloid beta-induced cognitive dysfunction rats by regulating PTK2B","volume":"31","author":"Liu","year":"2020","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejphar.2026.178721_bib89","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.devcel.2008.11.001","article-title":"A BBSome subunit links ciliogenesis, microtubule stability, and acetylation","volume":"15","author":"Loktev","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ejphar.2026.178721_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010012","article-title":"HDAC6 in diseases of cognition and of neurons","volume":"10","author":"LoPresti","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.178721_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169318","article-title":"Nucleocytoplasmic HDAC inhibition drives acetylation-dependent TDP-43 mislocalization and disulfide-linked oligomerization","volume":"437","author":"Lukianenko","year":"2025","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejphar.2026.178721_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.676214","article-title":"Loss of deacetylation enzymes Hdac6 and Sirt2 promotes acetylation of cytoplasmic tubulin, but suppresses axonemal acetylation in zebrafish cilia","volume":"9","author":"Lysyganicz","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2026.178721_bib93","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1097\/j.pain.0000000000001667","article-title":"Cell-specific role of histone deacetylase 6 in chemotherapy-induced mechanical allodynia and loss of intraepidermal nerve fibers","volume":"160","author":"Ma","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.178721_bib94","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/s41467-017-01690-2","article-title":"Critical role of the HDAC6-cortactin axis in human megakaryocyte maturation leading to a proplatelet-formation defect","volume":"8","author":"Messaoudi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.178721_bib95","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1440-1789.2011.01200.x","article-title":"Accumulation of histone deacetylase 6, an aggresome-related protein, is specific to lewy bodies and glial cytoplasmic inclusions","volume":"31","author":"Miki","year":"2011","journal-title":"Neuropathology"},{"key":"10.1016\/j.ejphar.2026.178721_bib96","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.neuron.2011.10.010","article-title":"ELP3 controls active zone morphology by acetylating the ELKS family member Bruchpilot","volume":"72","author":"Miskiewicz","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2026.178721_bib97","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.celrep.2014.05.051","article-title":"HDAC6 is a Bruchpilot deacetylase that facilitates neurotransmitter release","volume":"8","author":"Miskiewicz","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2026.178721_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.603710","article-title":"Autophagy in multiple sclerosis: two sides of the same coin","volume":"14","author":"Misrielal","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178721_bib99","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nchembio.2140","article-title":"Structural insights into HDAC6 tubulin deacetylation and its selective inhibition","volume":"12","author":"Miyake","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejphar.2026.178721_bib100","article-title":"Structure-based discovery of A small molecule inhibitor of histone deacetylase 6 (HDAC6) that significantly reduces Alzheimer's disease neuropathology","volume":"11","author":"Mondal","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.ejphar.2026.178721_bib101","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40035-023-00354-0","article-title":"Microtubule acetylation dyshomeostasis in Parkinson's disease","volume":"12","author":"Naren","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ejphar.2026.178721_bib102","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41580-018-0081-3","article-title":"Functions and mechanisms of non-histone protein acetylation","volume":"20","author":"Narita","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.178721_bib103","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/glia.22624","article-title":"HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes","volume":"62","author":"Noack","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.ejphar.2026.178721_bib104","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1083\/jcb.200611128","article-title":"Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6","volume":"178","author":"Olzmann","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.178721_bib105","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1128\/jvi.69.6.3584-3596.1995","article-title":"Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs","volume":"69","author":"Ou","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2026.178721_bib106","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nature05853","article-title":"HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS","volume":"447","author":"Pandey","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2026.178721_bib107","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbrc.2008.01.056","article-title":"Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors","volume":"368","author":"Park","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2026.178721_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/cells13070598","article-title":"The ZIKV NS5 protein aberrantly alters the tubulin cytoskeleton, induces the accumulation of autophagic p62 and affects IFN production: HDAC6 has emerged as an Anti-NS5\/ZIKV factor","volume":"13","author":"Perez-Yanes","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.178721_bib109","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1111\/j.1471-4159.2009.06102.x","article-title":"Tau--an inhibitor of deacetylase HDAC6 function","volume":"109","author":"Perez","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2026.178721_bib110","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.celrep.2017.01.028","article-title":"The role of histone deacetylase 6 in synaptic plasticity and memory","volume":"18","author":"Perry","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2026.178721_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113281","article-title":"HDAC6 inhibition promotes alpha-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in mice","volume":"328","author":"Picci","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2026.178721_bib112","doi-asserted-by":"crossref","first-page":"8054","DOI":"10.1021\/acs.jmedchem.8b01013","article-title":"Histone deacetylase 6-Selective inhibitors and the influence of capping groups on hydroxamate-zinc denticity","volume":"61","author":"Porter","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178721_bib113","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1172\/JCI137040","article-title":"Tau is not necessary for amyloid-beta-induced synaptic and memory impairments","volume":"130","author":"Puzzo","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2026.178721_bib114","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1515\/hsz-2015-0157","article-title":"Protein aggregate formation in oligodendrocytes: tau and the cytoskeleton at the intersection of neuroprotection and neurodegeneration","volume":"397","author":"Richter-Landsberg","year":"2016","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.178721_bib115","doi-asserted-by":"crossref","first-page":"19599","DOI":"10.1073\/pnas.0907935106","article-title":"HDAC6 is a target for protection and regeneration following injury in the nervous system","volume":"106","author":"Rivieccio","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2026.178721_bib116","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s40478-019-0750-2","article-title":"Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model","volume":"7","author":"Rossaert","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ejphar.2026.178721_bib117","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature05291","article-title":"The roles of intracellular protein-degradation pathways in neurodegeneration","volume":"443","author":"Rubinsztein","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2026.178721_bib118","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s00213-020-05525-9","article-title":"HDAC6-selective inhibitors decrease nerve-injury and inflammation-associated mechanical hypersensitivity in mice","volume":"237","author":"Sakloth","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2026.178721_bib119","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1182\/blood-2011-10-387365","article-title":"Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma","volume":"119","author":"Santo","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2026.178721_bib120","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neuron.2006.08.027","article-title":"An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a charcot-marie-tooth 2D mouse model","volume":"51","author":"Seburn","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2026.178721_bib121","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2217\/epi.14.69","article-title":"Histone deacetylase 6 in health and disease","volume":"7","author":"Seidel","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.ejphar.2026.178721_bib122","doi-asserted-by":"crossref","first-page":"8035","DOI":"10.1128\/MCB.21.23.8035-8044.2001","article-title":"Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways","volume":"21","author":"Seigneurin-Berny","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.178721_bib123","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/alzrt241","article-title":"Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition","volume":"6","author":"Selenica","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ejphar.2026.178721_bib124","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1523\/JNEUROSCI.0260-15.2015","article-title":"ApoE4 and abeta oligomers reduce BDNF expression via HDAC nuclear translocation","volume":"35","author":"Sen","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178721_bib125","article-title":"Erasers of histone acetylation: the histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Csh Perspect Biol."},{"key":"10.1016\/j.ejphar.2026.178721_bib126","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1871527317666181004155136","article-title":"Epigenetics in neurodegenerative diseases: the role of histone deacetylases","volume":"18","author":"Sharma","year":"2019","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.ejphar.2026.178721_bib127","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1021\/acschemneuro.5b00286","article-title":"Bicyclic-capped histone deacetylase 6 inhibitors with improved activity in a model of axonal Charcot-Marie-Tooth disease","volume":"7","author":"Shen","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178721_bib128","doi-asserted-by":"crossref","first-page":"8557","DOI":"10.1021\/acs.jmedchem.9b00946","article-title":"Discovery of a new Isoxazole-3-hydroxamate-Based histone deacetylase 6 inhibitor SS-208 with antitumor activity in syngeneic melanoma mouse models","volume":"62","author":"Shen","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178721_bib129","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/13543776.2019.1708901","article-title":"A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)","volume":"30","author":"Shen","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejphar.2026.178721_bib130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1326-8-7","article-title":"HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?","volume":"8","author":"Simoes-Pires","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejphar.2026.178721_bib131","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s11011-021-00823-3","article-title":"PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability","volume":"36","author":"Singh","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2026.178721_bib132","article-title":"HDAC6 inhibition by ITF3756 modulates PD-L1 expression and monocyte phenotype: insights for a promising immune checkpoint blockade co-treatment therapy","volume":"16","author":"Spadotto","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2026.178721_bib133","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1471-4159.2011.07180.x","article-title":"HDAC6 regulates aggresome-autophagy degradation pathway of alpha-synuclein in response to MPP+-induced stress","volume":"117","author":"Su","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2026.178721_bib134","article-title":"A selective inhibitor of histone deacetylase 3 prevents cognitive deficits and suppresses striatal CAG repeat expansions in Huntington's disease mice","volume":"7","author":"Suelves","year":"2017","journal-title":"Sci. Rep. Uk"},{"key":"10.1016\/j.ejphar.2026.178721_bib135","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.expneurol.2012.10.005","article-title":"Mercaptoacetamide-based class II HDAC inhibitor lowers abeta levels and improves learning and memory in a mouse model of Alzheimer's disease","volume":"239","author":"Sung","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2026.178721_bib136","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1021\/acschemneuro.0c00774","article-title":"Preclinical evaluation of an (18)F-Labeled SW-100 derivative for PET imaging of histone deacetylase 6 in the brain","volume":"12","author":"Tago","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178721_bib137","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/hmg\/ddg074","article-title":"Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein","volume":"12","author":"Taylor","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2026.178721_bib138","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.nbd.2014.02.012","article-title":"Early axonal loss accompanied by impaired endocytosis, abnormal axonal transport, and decreased microtubule stability occur in the model of Krabbe's disease","volume":"66","author":"Teixeira","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2026.178721_bib139","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1038\/s41467-020-19317-4","article-title":"An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline","volume":"11","author":"Trzeciakiewicz","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.178721_bib140","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0960-9822(00)00542-X","article-title":"Active maintenance of mHDA2\/mHDAC6 histone-deacetylase in the cytoplasm","volume":"10","author":"Verdel","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejphar.2026.178721_bib141","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1021\/acs.jmedchem.8b01090","article-title":"Synthesis and biological investigation of phenothiazine-based benzhydroxamic acids as selective histone deacetylase 6 inhibitors","volume":"62","author":"Vogerl","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178721_bib142","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201800078","article-title":"Histone lysine and genomic targets of histone acetyltransferases in mammals","volume":"40","author":"Voss","year":"2018","journal-title":"Bioessays"},{"key":"10.1016\/j.ejphar.2026.178721_bib143","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0968-0004(97)01016-5","article-title":"Histone acetylation: chromatin in action","volume":"22","author":"Wade","year":"1997","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejphar.2026.178721_bib144","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.neuron.2006.02.008","article-title":"Bruchpilot, a protein with homology to ELKS\/CAST, is required for structural integrity and function of synaptic active zones in Drosophila","volume":"49","author":"Wagh","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2026.178721_bib145","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62232","article-title":"Failures of nerve regeneration caused by aging or chronic denervation are rescued by restoring Schwann cell c-Jun","volume":"10","author":"Wagstaff","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.ejphar.2026.178721_bib146","article-title":"HAT- and HDAC-targeted protein acetylation in the occurrence and treatment of epilepsy","volume":"11","author":"Wang","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2026.178721_bib147","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00018-022-04341-y","article-title":"Upregulation of MDH1 acetylation by HDAC6 inhibition protects against oxidative stress-derived neuronal apoptosis following intracerebral hemorrhage","volume":"79","author":"Wang","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2026.178721_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117733","article-title":"Therapeutic potential of dual HDAC6\/SIRT2 inhibition in Alzheimer's disease","volume":"294","author":"Wang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178721_bib149","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.ejmech.2017.10.040","article-title":"Recent advances in the discovery of potent and selective HDAC6 inhibitors","volume":"143","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178721_bib150","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neulet.2009.10.037","article-title":"HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells","volume":"467","author":"Wang","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2026.178721_bib151","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1074\/jbc.M109.063354","article-title":"IIp45 inhibits cell migration through inhibition of HDAC6","volume":"285","author":"Wu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.178721_bib152","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fncel.2014.00068","article-title":"A selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: implications for Rett syndrome","volume":"8","author":"Xu","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178721_bib153","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082164","article-title":"General pathways of pain sensation and the major neurotransmitters involved in pain regulation","volume":"19","author":"Yam","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178721_bib154","doi-asserted-by":"crossref","first-page":"23375","DOI":"10.1021\/acs.jmedchem.5c02216","article-title":"Discovery of pyrazole-based positron emission tomography agent that maps histone deacetylase 6 (HDAC6) in the nonhuman primate brain","volume":"68","author":"Yamasaki","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178721_bib155","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.expneurol.2011.06.003","article-title":"Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis","volume":"231","author":"Yoo","year":"2011","journal-title":"Exp. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2026.178721_bib156","first-page":"13","article-title":"Secondary injury mechanisms in acute spinal cord injury","volume":"11","author":"Young","year":"1993","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.ejphar.2026.178721_bib157","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/hmg\/ddm272","article-title":"Disruption of neurofilament network with aggregation of light neurofilament protein: a common pathway leading to motor neuron degeneration due to charcot-marie-tooth disease-linked mutations in NFL and HSPB1","volume":"16","author":"Zhai","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2026.178721_bib158","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer's disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2026.178721_bib159","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3233\/JAD-140066","article-title":"Tubastatin A\/ACY-1215 improves cognition in Alzheimer's disease transgenic mice","volume":"41","author":"Zhang","year":"2014","journal-title":"J. Alzheimers Dis."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926002037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926002037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:51:47Z","timestamp":1779425507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926002037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":159,"alternative-id":["S0014299926002037"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178721","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging protein quality control and epigenetic dysregulation: The HDAC6 paradox in neurological disorders and therapeutic targeting","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178721"}}